Genome editing may enable researchers and clinicians to edit genes within the human genome to treat conditions like sickle cell anemia or cystic fibrosis, but the idea for such editing came to Jennifer Doudna at the University of California, Berkeley, as she was studying how bacteria avoid viral infections, NPR reports.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.